| |
|
|
| Name: |
VR Adviser LLC |
| City: |
New York |
| State: |
NY |
| Zip: |
10018 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
41 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APGE |
Apogee Therapeutics, Inc. |
1 |
- |
$43.38 |
$317,310,000 |
8,493,321 |
27% |
-67,437,000 |
0 |
14.521 |
N/A |
|
|
MTSR |
Metsera, Inc. |
2 |
New |
$28.59 |
$102,093,000 |
3,750,662 |
8.69% |
102,093,000 |
3,750,662 |
3.57 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
3 |
- |
$0.00 |
$93,549,000 |
12,762,462 |
7.96% |
-15,442,000 |
0 |
8.185 |
N/A |
|
|
ELVN |
Enliven Therapeutics Ord Shs |
4 |
- |
$0.00 |
$79,238,000 |
4,026,331 |
6.74% |
-11,354,000 |
0 |
8.014 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
5 |
- |
$11.41 |
$77,364,000 |
6,703,985 |
6.58% |
24,429,000 |
454,254 |
12.797 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
6 |
- |
$14.33 |
$52,339,000 |
3,882,709 |
4.45% |
-22,093,000 |
0 |
4.314 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
7 |
- |
$0.00 |
$48,870,000 |
3,112,720 |
4.16% |
-12,860,000 |
-107,410 |
0.752 |
N/A |
|
|
AGLE |
Aeglea Biotherapeutics, Inc. |
8 |
- |
$0.60 |
$43,330,000 |
2,685,448 |
3.69% |
-19,187,000 |
0 |
4.39 |
N/A |
|
|
ORKA |
Oruka Therapeutics, Inc |
9 |
- |
$11.08 |
$42,563,000 |
4,148,428 |
3.62% |
-21,145,000 |
862,808 |
11.853 |
Diagnostic Substances |
|
|
PRAX |
Praxis Precision Medicines,... |
10 |
- |
$0.00 |
$37,491,000 |
989,985 |
3.19% |
-38,698,000 |
0 |
1.89 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
11 |
- |
$7.10 |
$34,050,000 |
5,684,411 |
2.9% |
-10,288,000 |
0 |
4.358 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
12 |
- |
$0.70 |
$31,643,000 |
1,744,373 |
2.69% |
-6,384,000 |
0 |
5.367 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
13 |
- |
$9.57 |
$22,739,000 |
2,173,913 |
1.93% |
-28,478,000 |
0 |
1.884 |
N/A |
|
|
CDTX |
Cidara Therapeutics, Inc. |
14 |
- |
$49.45 |
$22,650,000 |
1,051,518 |
1.93% |
2,067,000 |
285,795 |
23.055 |
N/A |
|
|
ENGN |
Engene Holdings Inc. |
15 |
- |
$3.66 |
$22,608,000 |
5,046,414 |
1.92% |
-10,951,000 |
0 |
11.425 |
N/A |
|
|
ERAS |
Erasca, Inc. |
16 |
- |
$1.31 |
$22,216,000 |
16,216,216 |
1.89% |
-18,487,000 |
0 |
5.743 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
17 |
- |
$0.00 |
$17,759,000 |
3,182,527 |
1.51% |
-17,705,000 |
-1,212,000 |
4.512 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
18 |
- |
$10.93 |
$14,047,000 |
2,295,319 |
1.2% |
-23,688,000 |
0 |
4.331 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
19 |
- |
$5.57 |
$13,122,000 |
2,457,348 |
1.12% |
-8,847,000 |
0 |
4.147 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
20 |
- |
$0.00 |
$10,446,000 |
1,379,965 |
0.89% |
-6,362,000 |
0 |
0.317 |
N/A |
|
|
SLDB |
Solid Biosciences Inc |
21 |
New |
$4.72 |
$9,181,000 |
2,481,400 |
0.78% |
9,181,000 |
2,481,400 |
6.429 |
N/A |
|
|
SVRA |
Savara Inc |
22 |
New |
$2.21 |
$9,024,000 |
3,257,639 |
0.77% |
9,024,000 |
3,257,639 |
1.979 |
Biotechnology |
|
|
ABVX |
Abivax S.A |
23 |
- |
$7.40 |
$8,411,000 |
1,345,780 |
0.72% |
-1,440,000 |
0 |
2.171 |
N/A |
|
|
PCSC |
Perceptive Capital Solution... |
24 |
- |
$0.00 |
$7,725,000 |
750,000 |
0.66% |
90,000 |
0 |
8.417 |
N/A |
|
|
SRZN |
Surrozen Ord Shs |
25 |
New |
$0.50 |
$7,380,000 |
632,931 |
0.63% |
7,380,000 |
632,931 |
1.807 |
N/A |
|
|
ZURA |
Zura Bio Ltd |
26 |
- |
$1.05 |
$6,480,000 |
5,023,166 |
0.55% |
1,422,000 |
3,000,000 |
7.947 |
N/A |
|
|
ARTV |
Artiva Biotherapeutics, Inc. |
27 |
- |
$0.00 |
$4,829,000 |
1,609,569 |
0.41% |
-11,395,000 |
0 |
6.625 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
28 |
- |
$0.00 |
$3,872,000 |
615,506 |
0.33% |
-1,346,000 |
-650,951 |
0.605 |
N/A |
|
|
APLT |
Applied Therapeutics Inc. |
29 |
- |
$0.00 |
$2,722,000 |
5,567,709 |
0.23% |
-5,832,000 |
-4,422,882 |
4.848 |
N/A |
|
|
FDMT |
4d Molecular Therapeutics Inc. |
30 |
- |
$0.00 |
$2,189,000 |
677,600 |
0.19% |
-14,256,000 |
-2,274,771 |
1.09 |
N/A |
|
|
CASI |
Casi Pharmaceuticals Inc |
31 |
- |
$1.63 |
$2,132,000 |
987,259 |
0.18% |
-662,000 |
0 |
0.797 |
Biotechnology |
|
|
TENX |
Tenax Therapeutics Inc |
32 |
- |
$0.26 |
$1,365,000 |
208,333 |
0.12% |
75,000 |
0 |
0.466 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
33 |
- |
$0.29 |
$1,230,000 |
3,574,325 |
0.1% |
-13,439,000 |
-6,683,465 |
2.964 |
N/A |
|
|
IPSC |
Century Therapeutics, Inc. |
34 |
- |
$0.00 |
$1,189,000 |
2,498,069 |
0.1% |
-2,808,000 |
-1,459,117 |
4.557 |
N/A |
|
|
TNYA |
Tenaya Therapeutics, Inc. |
35 |
- |
$0.00 |
$887,000 |
1,555,556 |
0.08% |
-1,337,000 |
0 |
2.431 |
N/A |
|
|
GLYC |
Glycomimetics Inc |
36 |
- |
$0.16 |
$630,000 |
3,000,000 |
0.05% |
-117,000 |
0 |
6.272 |
N/A |
|
|
TIL |
Instil Bio Ord Shs |
37 |
- |
$0.00 |
$576,000 |
33,177 |
0.05% |
-57,000 |
0 |
0.026 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
39 |
Closed |
$3.83 |
$0 |
0 |
0% |
-5,967,000 |
-1,077,090 |
0 |
N/A |
|
|
AQST |
Aquestive Therapeutics, Inc. |
38 |
Closed |
$3.25 |
$0 |
0 |
0% |
-9,362,000 |
-2,629,786 |
0 |
N/A |
|
|
MRUS |
Merus Nv |
41 |
Closed |
$52.99 |
$0 |
0 |
0% |
-24,911,000 |
-592,411 |
0 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
40 |
Closed |
$0.00 |
$0 |
0 |
0% |
-5,580,000 |
-3,225,180 |
0 |
N/A |
|
